Last mentioned: Mar 7, 2026
Institutional analysts are intensifying their scrutiny of Figma and DaVita as both companies navigate pivotal transitions in the SaaS and healthcare sectors. While Figma solidifies its post-IPO independence through AI-driven design tools, DaVita is increasingly leveraging cloud-based predictive analytics to maintain its dominance in the dialysis market.
This page surfaces every story mentioning Dylan Field across our saas coverage. We track each entity's appearance over time so readers can trace how the narrative evolves — which developments are isolated incidents, which build into longer arcs, and which reframe how operators in the space think about the entity. Story selection uses the same multi-source verification gate applied across the rest of our coverage.
Read our editorial methodology for how we identify, deduplicate, and score entity references. Our glossary defines the technical terms used across stories on this page, and our trends index contextualizes individual developments against the longer-running saas beat. Cross-entity comparisons live on our compare view.
| What you see | What it tells you |
|---|---|
| Story count | Number of distinct stories where Dylan Field was a primary or referenced actor. |
| Recency clustering | Whether mentions are concentrated in a recent window (a news cycle) or distributed (a sustained arc). |
| Sentiment distribution | Aggregate sentiment of the stories mentioning this entity, weighted by impact score. |
| Cross-niche links | When the same entity surfaces in our sibling networks, we link to those views to enrich context. |